Project Grant R01AG093879
Award Date
6/1/25
Completion Date
3/31/30
Dollars Obligated
$845K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
This $4,950,026 project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The Icahn School of Medicine at Mount Sinai is investigating potential synergy between HIV infection and amyloid beta, a hallmark of Alzheimer's disease, in promoting memory impairment. Researchers will characterize enhanced HIV neuropathogenesis in familial and late-onset Alzheimer's disease mouse models...
This $745,765 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York aims to investigate the effects of Alzheimer's disease (AD) risk genes and aging on human microglia activity and lipid metabolism. The key focus is on understanding how genetic variants associated with increased AD risk or longevity may impact microglia's ability to clear cholesterol/lipid-rich cellular debris, a critical...
This $1,758,779 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by the Winifred Masterson Burke Medical Research Institute to assess neuronal vulnerability in the entorhinal cortex due to Alzheimer's disease pathology. The key objectives are to determine whether hyperexcitability in Alzheimer's disease is caused by dysfunction of excitatory or inhibitory neurons in the entorhinal cortex, and to modulate neuronal activities to...
This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), provides $6,226,692 to The Trustees of Columbia University in the City of New York to conduct research on the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the progression of Alzheimer's disease. The research aims to identify key early events in Alzheimer's disease pathology, particularly in the locus coeruleus and hippocampus regions of the brain, and...
This $3.6 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research at the Icahn School of Medicine at Mount Sinai directed at understanding the role of glial cell interactions surrounding amyloid plaques in the progression of Alzheimer's disease. As part of the Aging Research program (CFDA 93.866), the three-year award will support investigation of how deletion of the Plexin-B1 gene impacts glial network formation and the...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $2,173,794.00 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research aimed at developing strategies to enhance adult hippocampal neurogenesis (AHN) and brain-derived neurotrophic factor (BDNF) as a potential therapeutic approach for treating cognitive decline in Alzheimer's disease (AD). The research project seeks to: 1) explore the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Icahn School of Medicine at Mount Sinai provides $842,114 to systematically investigate the molecular mechanisms of brain senescence in different molecular subtypes of Alzheimer's disease (AD). The project aims to identify and characterize senescent cells in major subtypes of AD using advanced single-cell multi-omics and spatial transcriptomics techniques. This comprehensive research initiative is...
This $498,748 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research program) will fund research at the University of Massachusetts Medical School to elucidate the mechanisms by which the MS4A gene family regulates neurodegeneration in Alzheimer's disease and related disorders. The key objectives of this one-year grant are to: 1) determine the effects of deleting individual or multiple MS4A gene family members on neurodegenerative phenotypes in mouse...
The National Institute on Aging (CFDA 93.866 Aging Research) awarded a $148,568 Project Grant to Brandeis University to conduct research on the neurobiological mechanisms underlying daily life activity participation in older adults and its linkages to Alzheimer's disease pathology. The proposed research will use a multilevel, multimodal framework to study the behavioral and neurobiological mechanisms of age-related shifts in motivation to perform cognitively effortful activities, and directly...
This $2,044,038 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research study at New York University School of Medicine examining the role of the thalamo-hippocampal-prefrontal circuit in driving anxiety in Alzheimer's disease (AD). The study aims to elucidate AD-related changes in the functional synaptic architecture of this circuit, determine the in vivo activity of its neural populations during anxious behavior in AD mouse models, and test...